thecomfortzone.design
Open in
urlscan Pro
18.67.39.102
Public Scan
URL:
https://thecomfortzone.design/
Submission: On January 10 via api from US — Scanned from US
Submission: On January 10 via api from US — Scanned from US
Form analysis
0 forms found in the DOMText Content
Comfort is key uncomfortable options critical issue new comfort zone 21grams X Comfort is key uncomfortable options critical issue new comfort zone 21grams COMFORT IS KEY WE WANTED TO HELP MAKE THINGS AS PAINLESS AS POSSIBLE, SO ENJOY THIS EASY-GOING SCROLL THROUGH OUR PROPOSAL. Everyone has their favorite chair and special blanket to get cozy with. That's exactly what this site was designed to feel like. ON THE GO? Listen to the calming voice of Julie Andrews take you through the proposal instead. Yea, she's a friend. BRINGING ACROMEGALY TREATMENT TO THE COMFORTS OF HOME CAM2029 NOT ONLY MAKES EFFECTIVE TREATMENT LESS PAINFUL, BUT PATIENTS CAN ALSO GIVE IT TO THEMSELVES IN THE COMFORT OF THEIR OWN HOMES. LESS PAINFUL DELIVERY AND FEWER INJECTION SITE REACTIONS AT-HOME, ONCE-MONTHLY ADMINISTRATION FAVORABLE CLINICAL PROFILE THE EFFICACY OF A TRUSTED DRUG, WITH LESS BURDENSOME DELIVERY. PATIENTS ARE UNCOMFORTABLE WITH THEIR CURRENT OPTIONS, BUT THINK THEM A NECESSARY EVIL PAIN POINTS * LARGE, PAINFUL NEEDLES FOR INJECTION * LINGERING PAIN AND DISCOMFORT AT ADMINISTRATION SITE * LOGISTICS AND TIME SPENT TRAVELING TO ONCE-MONTHLY OFFICE VISITS "WHEN I FIRST STARTED TREATMENT, I USED TO HAVE TO DRIVE 45 MILES ONE-WAY DOWNTOWN. IT WAS A 3-HOUR TRIP DRIVING, AN HOUR WAITING, AN HOUR GETTING MY SHOT, AND THEN DRIVING BACK HOME. AND THAT WAS REALLY STRESSFUL." -KELLY, PATIENT ENDOCRINOLOGISTS AND PATIENTS ARE NOT ON THE SAME PAGE PATIENTS ARE UNCOMFORTABLE WITH THEIR CURRENT OPTIONS PHYSICIANS ARE COMFORTABLE WITH THE CURRENT TREATMENT PARADIGM HEAR THE DISCONNECT FOR YOURSELF POSITION CAM2029 AS THE BRAND THAT PROVIDES THE COMFORT OF CONTROL WITHOUT DREAD INSIGHT PATIENTS AND HCPS DON’T REALIZE THAT BETTER COULD BE OUT THERE, SO THEY SETTLE FOR SUBPAR ACROMEGALY TREATMENTS. HCPS FOCUS ONLY ON WHAT THEY CAN CONTROL, AND PATIENTS DO WHATEVER THEY HAVE TO DO TO FIND RELIEF. BENEFIT CAM2029 ELEVATES THE SRL TREATMENT EXPERIENCE WITH ITS INNOVATIVE DELIVERY SYSTEM; PROVIDING A COMPARABLE CLINICAL PROFILE YOU WOULD EXPECT FROM AN OCTREOTIDE, WITH A SMALLER, LESS PAINFUL NEEDLE AND ONCE-MONTHLY DOSING THAT CAN BE ADMINISTERED IN THE COMFORT OF HOME. HERE’S HOW WE BRING THIS TO LIFE CREATIVELY OBVIOUS INSIGHT THE TREATMENT BURDEN OF SRLS IS REAL——CONSISTING OF LARGE, PAINFUL NEEDLES, LINGERING ADMINISTRATION SITE DISCOMFORT, AND INCONVENIENCE OF TRAVELING TO ONCE-MONTHLY OFFICE VISITS. THERE IS UNDENIABLE UNMET NEED FOR A NEW TREATMENT DELIVERY OPTION THAT OFFERS A BETTER EXPERIENCE. DEEPER INSIGHT THERE IS CHASM BETWEEN HCPS AND PATIENTS THAT LEAVES HCPS BLIND TO THE UNMET NEED THAT PATIENTS FEEL DEEPLY. BECAUSE PATIENTS SILENTLY SUFFER FROM THE TREATMENT BURDEN OF FIRST-LINE SRLS WHILE HCPS FOCUS ON CONTROL, HCPS DRAMATICALLY UNDERESTIMATE OR DISMISS THE IMPACT OF THIS TREATMENT DISCOMFORT. BRAND ROLE CAM2029 IS THE ADVOCATE THAT UNITES PATIENTS AND HCPS IN THE AMBITION FOR BETTER. IT’S THE NEXT-GENERATION SRL THAT PROVIDES THE EFFICACY OF A TRUSTED DRUG IN A NEW FORMULATION THAT OFFERS A LESS BURDENSOME DELIVERY. FINALLY, PATIENTS AND HCPS CAN HAVE COMFORT OF CONTROL WITHOUT DREAD. THE ‘21 GRAMS’ THE NEW COMFORT ZONE New York Times | March 11, 1907 WHO ARE WE? 21 GRAMS IS NOT JUST OUR NAME. IT’S THE PHILOSOPHY, APPROACH, AND REASON WE’VE BECOME THE FASTEST GROWING HEALTHCARE AGENCY ON THE PLANET, WITHIN THE PAST 5 YEARS. LEARN MORE ABOUT THE STORY BEHIND OUR NAME HERE WE LIVE BY A SIMPLE BELIEF MEDICINE CAN CHANGE PEOPLE’S LIVES. AIR JORDANS JUST GO ON THEIR FEET. SO HOW CAN SNEAKERS MAKE PEOPLE FEEL SO MUCH, AND HEALTH, SO LITTLE? BY NOT JUST FOCUSING ON FEATURES AND BENEFITS. BUT BY TAPPING INTO THE HUMAN SPIRIT. AND WE WANT TO HELP YOU DISCOVER THE SOUL OF COMFORTABLE TREATMENT